Association between serum KIT and SCF levels. (A) Samples taken within 1 week of starting imatinib therapy (BL indicates baseline; Spearman rank correlation coefficient .069; P = .84). (B) Samples taken during imatinib therapy (correlation coefficient -.34; P = <.0001).